Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05731986 · ClinicalTrials.gov registry record · NA

Spinal Cord Transcutaneous Stimulation Effect on Blood Pressure in Acute Spinal Cord Injury (SCI)

A NA study of Cardiovascular Diseases and Spinal Cord Injuries, sponsored by Kessler Foundation.

Recruiting
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT05731986 is a NA study of Cardiovascular Diseases and Spinal Cord Injuries that is actively recruiting participants, run by Kessler Foundation. The registered enrollment target is 12 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05731986, a NA study of Cardiovascular Diseases and Spinal Cord Injuries, is actively recruiting participants, sponsored by Kessler Foundation.

RECRUITING
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to evaluate the effect of transcutaneous spinal cord stimulation on blood pressure in individuals with an acute spinal cord injury (within 30 days of injury). Blood pressure instability, specifically orthostatic hypotension (a drop in blood pressure when moving lying flat on your back to an upright position), appears early after the injury and often significantly interferes with participation in the critical rehabilitation time period. The main questions it aims to answer are: 1. Can optimal spinal stimulation increase blood pressure and resolve orthostatic symptoms (such as dizziness and nausea) when individuals undergo an orthostatic provocation (a sit-up test)? Optimal stimulation and sham stimulation (which is similar to a placebo treatment) will be compared. 2. What are the various spinal sites and stimulation parameters that can be used to increase and stabilize blood pressure to the normal range of 110-120 mmHg? Participants will undergo orthostatic tests (lying on a bed that starts out flat and then moved into an upright seated position by raising the head of bed by 90° and dropping the base of the bed by 90° from the knee) with optimal and sham stimulation, and their blood pressure measurements will be evaluated and compared.

Interventions

  • DIAGNOSTIC_TEST Orthostatic challenge
  • DEVICE Biostim-5 transcutaneous spinal stimulation - Mapping
  • DEVICE Biostim-5 transcutaneous spinal stimulation - "Optimal" testing
  • DEVICE Biostim-5 transcutaneous spinal stimulation - "Sham" testing

Study Locations (1)

New Jersey

  • Kessler Foundation - West Orange

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2023-12-01
Est. Completion 2026-08
Phase NA

Sponsor

Kessler Foundation

104 total trials

What the Registry Record Tells You About NCT05731986

The ClinicalTrials.gov registry entry for NCT05731986 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The listed sponsor is Kessler Foundation, which has 104 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 4 interventions - of which Orthostatic challenge is the first listed.

NCT05731986 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT05731986 about?

NCT05731986 is a clinical study titled "Spinal Cord Transcutaneous Stimulation Effect on Blood Pressure in Acute Spinal Cord Injury (SCI)". The goal of this clinical trial is to evaluate the effect of transcutaneous spinal cord stimulation on blood pressure in individuals with an acute spinal cord injury (within 30 days of injury). Blood pressure instability, specifically orthostatic hypotension (a drop in blood pressure when moving lyi...

What is the current status of trial NCT05731986?

This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2023-12-01. Estimated completion is 2026-08.

What conditions does trial NCT05731986 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, Spinal Cord Injuries, Blood Pressure, Nervous System Diseases, Orthostatic Hypotension.

What interventions are being tested in trial NCT05731986?

The interventions under investigation include: Orthostatic challenge (DIAGNOSTIC_TEST), Biostim-5 transcutaneous spinal stimulation - Mapping (DEVICE), Biostim-5 transcutaneous spinal stimulation - "Optimal" testing (DEVICE), Biostim-5 transcutaneous spinal stimulation - "Sham" testing (DEVICE).

Who is sponsoring clinical trial NCT05731986?

This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05731986 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.